Florida so far has rejected expanding Medicaid benefits to nearly all poor adults, but several factors could change that soon.» Read More
A tweet or phone call could be the answer to containing the spread of the deadly Ebola virus, according to mobile researchers .
Obamacare's small business health marketplaces are likely to fall well short of the 2 million enrollees projected for 2014, a GAO report suggests.
A surgeon infected with Ebola in Sierra Leone will be flown to the University of Nebraska Medical Center for treatment.
UK patients could soon be "prescribed" a smartphone application instead of a medical prescription when visiting their doctor.
By reviewing the Obamacare law yet again, Supreme Court justices could find themselves in the political crosshairs.
With PlayStation Vue, Sony joins the ranks of companies looking to shake up the cable and satellite business.
HealthCare.gov allows window-shopping on Obamacare plans that go on sale Saturday, and data suggest that price increases, if any, will be modest.
Experts are meeting in Brussels to debate whether some materials like plastic bottles could be dangerous.
Obamacare's excise tax on pricey health plans will hit both employers and workers with some steep costs, a new analysis shows.
Mobile payments may be all the rage, but a Canadian based start-up is betting that some consumers will want to wear their payment source.
There is no shortage of data driven dating services, but a start-up called SingldOut is using a much more personal data set to help people find love.
The White House has managed to move forward from Veteran Affairs health care scandal, among other events, reports NBC News.
China's healthcare sector is growing at more than double the pace of the overall economy, according to the CEO of Johnson & Johnson.
The Obama administration says less than 10 million people are likely to sign up for Obamacare by 2015, much less than 13 million projected earlier.
NASH, or nonalcoholic steatohepatitis, is a liver disease that may affect as much as 12 percent of the U.S. population, Genfit's Dean Hum said.
Merck hoped to trump Gilead's hepatitis C treatment with its own shorter therapy, but early results show the four-week regimen may not be successful.
Did Obamacare have an inadvertent poison pill in there all along?
Arrowhead Research Chief Executive Chris Anzalone contends the company's hepatitis B therapy, ARC-520, has potential.
Craig Spencer, the New York City doctor who contracted Ebola, is being released from Bellevue Hospital Center, the NYT reports.
Apple's online store lists a lot of fitness-related products, but don't look for Fitbit.
Get the best of CNBC in your inbox